Fidelity Investments’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANRO
Fidelity Investments's ANRO Position: Q3 2026 in Review
Fidelity Investments increased its Alto Neuroscience (ANRO) stake by 2,283% in Q3 2026, buying an estimated $4.34M and bringing the position to 150,749 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2547.
Fidelity Investments first reported a position in ANRO in Q1 2024 and has held it in 11 quarters since. The position peaked at $36.1M in Q1 2024. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.
- Fidelity Investments held 150,749 shares of Alto Neuroscience worth $3.85M as of Q3 2026.
- Fidelity Investments bought 144,424 Alto Neuroscience shares in Q3 2026, an estimated $4.34M.
- Alto Neuroscience made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2547 holding.
- Fidelity Investments first reported a position in Alto Neuroscience in Q1 2024 and has held it in 11 quarters since.
- Fidelity Investments's Alto Neuroscience position peaked at $36.1M in Q1 2024.
- 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.